Purple Biotech (PPBT) Receivables (2019 - 2025)

Purple Biotech (PPBT) reported Receivables of $431000.0 for Q4 2022, down 13.8% on a QoQ basis from $500000.0 in Q4 2020.

Purple Biotech (PPBT) has 3 years of Receivables data on file, last reported at $431000.0 in Q4 2022.

  • Quarterly Receivables changed N/A year-over-year to $431000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $431000.0 (changed N/A YoY) and the FY2022 annual result came in at $431000.0, changed N/A from the prior year.
  • Receivables declined to $431000.0 in Q4 2022 per PPBT's latest filing, from $500000.0 in the prior quarter.
  • Across five years, Receivables topped out at $1.5 million in Q4 2019 and bottomed at $431000.0 in Q4 2022.
  • The 3-year median for Receivables is $500000.0 (2020), against an average of $808000.0.
  • Peak annual rise in Receivables reached 66.51% in 2020, while the deepest fall reached 66.51% in 2020.
  • Tracing PPBT's Receivables over 3 years: stood at $1.5 million in 2019, then plunged by 66.51% to $500000.0 in 2020, then declined by 13.8% to $431000.0 in 2022.
  • Per Business Quant, the three latest PPBT Receivables figures stand at $431000.0 (Q4 2022), $500000.0 (Q4 2020), and $1.5 million (Q4 2019).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 13.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 4.15 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 2.00 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 5.73 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 883.96 Mn
10 Purple Biotech 3.58 Bn 3.57 Bn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 326,000.00
Mar 31, 2025 469,000.00
Dec 31, 2024 276,000.00
Sep 30, 2024 14,000.00
Jun 30, 2024 22,000.00
Mar 31, 2024 21,000.00
Dec 31, 2023 74,000.00
Sep 30, 2023 138,000.00
Jun 30, 2023 352,000.00
Mar 31, 2023 386,000.00
Dec 31, 2022 431,000.00
Sep 30, 2022 187,000.00
Jun 30, 2022 187,000.00
Mar 31, 2022 187,000.00
Dec 31, 2021 193,000.00
Sep 30, 2021 500,000.00
Jun 30, 2021 500,000.00
Mar 31, 2021 500,000.00
Dec 31, 2020 500,000.00
Jun 30, 2020 1.00 Mn
Dec 31, 2019 1.49 Mn